BBH

VanEck Vectors Biotech ETF

Down$125.45
$-0.15
(-0.12%)
As of 4:59:51 PM EDT | 1/23/19  |  Market Closed

BBH Trading Data

Open

$126.35

Low Price

$124.08

High Price

$127.27

Previous Last Price

$125.6

Bid Size

$125.46 X 100

Ask Size

$125.55 X 100

BBH Portfolio Data

AUM

$414,271,200

Shares

3,297

PE Ratio

25.69

Price / Book Ratio

3.73

Expense Ratio

0.35

Net Asset Value

$125.67

Volume

Volume

23,384

Avg. Volume (YDT)

25,260

Dollar Volume

$2,458,374

Weekly Avg. Volume

32,620

Monthly Avg. Volume

34,380

Quarterly Avg. Volume

29,044

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
8.77%
Gilead Sciences Inc (GILD)
6.54%
Celgene Corp (CELG)
6.04%
Vertex Pharmaceuticals Inc (VRTX)
5.51%
Regeneron Pharmaceuticals Inc (REGN)
5.5%
Allergan Plc (AGN)
5.22%
Biogen Inc (BIIB)
5.19%
Incyte Corp (INCY)
5.18%
Exact Sciences Corp (EXAS)
4.9%
Iqvia Holdings Inc (IQV)
4.64%

Total BBH Holdings

Total Holdings: 26

Amgen Inc (AMGN)
8.77%
Gilead Sciences Inc (GILD)
6.54%
Celgene Corp (CELG)
6.04%
Vertex Pharmaceuticals Inc (VRTX)
5.51%
Regeneron Pharmaceuticals Inc (REGN)
5.5%
Allergan Plc (AGN)
5.22%
Biogen Inc (BIIB)
5.19%
Incyte Corp (INCY)
5.18%
Exact Sciences Corp (EXAS)
4.9%
Iqvia Holdings Inc (IQV)
4.64%
Biomarin Pharmaceutical Inc (BMRN)
4.62%
Illumina Inc (ILMN)
4.61%
Alexion Pharmaceuticals Inc (ALXN)
4.47%
Qiagen Nv (QGEN)
4.1%
Sarepta Therapeutics Inc (SRPT)
3.78%
Charles River Laboratories Internationa (CRL)
2.96%
Grifols Sa (GRFS)
2.81%
Neurocrine Biosciences Inc (NBIX)
2.74%
Nektar Therapeutics (NKTR)
2.48%
Alnylam Pharmaceuticals Inc (ALNY)
2.39%
United Therapeutics Corp (UTHR)
2.35%
Ionis Pharmaceuticals Inc (IONS)
1.91%
Seattle Genetics Inc (SGEN)
1.9%
Bluebird Bio Inc (BLUE)
1.61%
Market Vectors Biotech ETF (BBH)
0%
0%

BBH Technicals

Alpha

-9.89

Beta

1.17

Leverage

Long

Standard Deviation

7.09

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

4.42

BBH Performance

YTD Return

13.3%

1 Year Return

-5.44%

3 Year Return

23.56%

5 Year Return

29.64%

10 Year Return

122.25%

BBH Related Articles